Zimmer Biomet Holdings, Inc. (ZBH)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for ZBH is $103.48, 9.0% above the last close of $94.98 on Oct 16, 2026; targets range from $90.42 to $122.52. Rating consensus: Hold.
Snapshot
- P/E23.1x
- P/E vs sector-17.9%
- P/E vs own-1.9%
- Target upside+9.0%
- ConsensusHold
- Market cap$18.12B
- FCF yield+10.1%
- Insiders-$824K
- Earnings in19d
- News0.00
Why it moved
Zimmer Biomet Holdings, Inc. (ZBH) rose 0.6% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to ZBH.
0 stories on the day (30-day average 0.3).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $94.98 · -3.9% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▼ 100▲ 200▲
- Above MAs3 of 4 above
- MA20×50—
- RSI58
- Support-0.4%
- Resistance+4.5%
- Off 52w high-7.7%
- Off ATH-42.5%
- 52w range$94.98
- Bollingerupper half
- MACD0.77
- ATR+2.6%
- Volume1.0x
Analyst price targets
12 firms with a target in the last 12 months · last close $94.98 · as of Oct 16, 2026
Strong buy 3 · Buy 6 · Hold 19 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +4.8% year over year, free cash flow 15.2% of revenue, operating margin 15.0%.
| Q2 FY2026 | Jun 30, 2026 | $2.18B | 1.03 | $331M | 70.8% | 15.0% | 9.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.09B | 1.22 | $284M | 72.4% | 17.9% | 11.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.24B | 0.70 | $669M | 64.7% | 12.8% | 6.2% |
| Q3 FY2025 | Sep 30, 2025 | $2B | 1.16 | $546M | 72.1% | 17.6% | 11.5% |
| Q2 FY2025 | Jun 30, 2025 | $2.08B | 0.77 | $298M | 71.5% | 14.4% | 7.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.91B | 0.91 | $336M | 71.2% | 15.3% | 9.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.02B | 1.20 | $421M | 71.0% | 19.2% | 11.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.82B | 1.23 | $369M | 70.5% | 15.3% | 13.7% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 2 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 3 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 4 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 5 |  | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 6 | | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 7 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 8 |  | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.